Continued Progress Towards Optimizing Clinical Development Plans
On Track to Initiate Phase 2b Study of Omilancor in Ulcerative Colitis Later this Year
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Continued Progress Towards Optimizing Clinical Development Plans
On Track to Initiate Phase 2b Study of Omilancor in Ulcerative Colitis Later this Year
Read more at globenewswire.com